Promising New PD Fluid
In a Phase 2 study, PD-protec® from Zytoprotec in Vienna, Austria, reduced the risk of peritonitis and of membrane failure. The new fluid was well-tolerated, with no adverse events. Once on the market, this fluid could improve PD outcomes and allow more people to stay longer on the therapy.
Read the full article » | Posted 07-14-2017
Related Articles
- HD with Saline and No Blood Thinner? Posted 06-11-2025
- AWAK is now Singapore-based Vivance Posted 05-20-2025
- Archimedes by Simergent Promises Quieter, Less Painful APD Posted 05-20-2025
- PeritoneX by Relavo Medical Posted 05-20-2025